Virtu KCG Holdings’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Virtu KCG Holdings’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,417	Closed	-$15K	–	4241
2016 Q4	$15K	Buy	+21,417	New	+$25.5K	﹤0.01%	3264
2016 Q2	–	Sell	-12,285	Closed	-$26K	–	3709
2016 Q1	$26K	Buy	+12,285	New	+$33.9K	﹤0.01%	2569

Other funds holding PARN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Virtu KCG Holdings's PARN Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 21,417 shares — an estimated $15K sold.

Virtu KCG Holdings first reported a position in PARN in Q1 2016 and held it in 2 quarters. The position peaked at $26K in Q1 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

Virtu KCG Holdings reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 21,417 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $15K.
Virtu KCG Holdings first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q1 2016 and held it in 2 quarters.
Virtu KCG Holdings's Parnell Pharmaceuticals Holdings Ltd position peaked at $26K in Q1 2016.
2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.